Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Glycine N-methyltransferase deficiency

MONDO:0011698

Glycine N-methyltransferase deficiency (GNMT deficiency) is a very rare condition characterized by persistent and isolated excess levels of methionine in the blood (hypermethioninemia). The only clinical abnormalities are mild increase of the liver size (hepatomegaly) and chronic elevation of the transaminase levels in the blood without liver disease. Methionine may also be increased in urine. However, because elevated levels of methionine in the blood itself is a risk factor for development of neurological signs and symptoms, people with GNMT deficiency can have neurological problems when methionine levelsare greater than 800μmol/L. GNMT deficiency is caused by mutations in the GNMT gene. Inheritance is autosomal recessive. Treatment is not needed in most cases.

Also known as: GNMT deficiency, Glycine N-methyltransferase deficiency, glycine N-methyltransferase deficiency, hypermethioninemia due to GNMT deficiency, hypermethioninemia due to glycine N-methyltransferase deficiency

1 clinical trial for this condition and its sub-types, 0 tagged with Glycine N-methyltransferase deficiency itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.